Objectives: The purpose of this study was to investigate the seasonal and epidemic distribution of the disease in the environment of Ioannina prefecture, with a population of 158,000 and a climate of a transitive zone between Mediterranean and continental. Patients: This retrospective study included 125 patients suffering from idiopathic peripheral facial paralysis, treated from 1995 until 1999. The male:female ratio was 62:63. The age of the patients ranged from 7 to 84 years, with a mean age of 50.4 ± 21.8. The annual incidence of the disease was 15.8 per 100,000 population during the 5 years. Results: Correlation between the disease frequency and the age of the patients revealed an increased frequency in patients over 40 years (67.2%) and peak morbidity during the 7th decade (36%). There was no significant difference in the number of cases occurring during the cold – warm half of the year, the four seasons, and in the monthly distribution. By calculating the mean intervals in days between successive cases per month and per season, we observed no significant differences. Conclusions: Our study did not provide any statistically significant results that could indicate seasonal or epidemic distribution of Bell’s palsy.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.